Delta 9 Cannabis Inc. (TSX:DN) has announced that, on August 6, 2021, it received approval from Health Canada for two expansions at its Winnipeg-based cultivation, processing, and distribution facilities.
The approvals allow for an expansion of the company’s licensed perimeter at its Winnipeg-based facilities, expanding the area currently under license from approximately 80,000 square feet to approximately 95,000 square feet, and the licensing of a new 7,500 square foot purpose-built storage and distribution area.
Delta 9 said the expanded licensed perimeter will allow it to improve control systems within its licensed perimeter, improve the operational flow of its operations, and to position the company to better plan for future expansions of its licensed cannabis operations areas.
READ: Delta 9 Cannabis sees its 2Q revenue climbing as much as 33% to C$17.3M
The new purpose-built storage and distribution area will allow Delta 9 to improve its product packaging, case-packing, and distribution efficiency to better allow it to cater to its provincial distribution markets across Canada, it added.
The company said it anticipates that the new storage area will improve its value proposition in various provincial markets across the country.
Delta 9 is a vertically integrated cannabis company focused on bringing the highest quality products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses.
The company's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada.
Delta 9 also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand.
Contact the author at jon.hopkins@proactiveinvestors.com